OSE Immunotherapeutics SA (EPA:OSE)
4.930
+0.050 (1.02%)
May 14, 2026, 5:37 PM CET
OSE Immunotherapeutics Market Cap
OSE Immunotherapeutics has a market cap or net worth of €110.53 million as of May 14, 2026. Its market cap has decreased by -20.40% in one year.
Market Cap
110.53M
Enterprise Value
118.39M
Revenue
1.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.93
Market Cap Chart
Since March 30, 2015, OSE Immunotherapeutics's market cap has increased from 104.30M to 110.53M, an increase of 5.98%. That is a compound annual growth rate of 0.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 110.53M | -4.27% |
| Dec 31, 2025 | 115.47M | -26.37% |
| Dec 31, 2024 | 156.83M | 94.71% |
| Dec 29, 2023 | 80.55M | -34.73% |
| Dec 30, 2022 | 123.40M | -34.26% |
| Dec 31, 2021 | 187.71M | 45.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cellectis | 245.21M |
| Sensorion | 213.87M |
| Transgene | 212.53M |
| MaaT Pharma | 135.67M |
| ABIONYX Pharma | 128.41M |
| Innate Pharma | 118.41M |
| Adocia | 96.60M |
| Valerio Therapeutics Société anonyme | 83.91M |